---
figid: PMC4571892__zbc0401524110006
figtitle: Impact of HER2-mediated inhibition of MLK3 kinase activity on breast cancer
  cell death and tumorigenesis (survival)
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
- Arabidopsis thaliana
pmcid: PMC4571892
filename: zbc0401524110006.jpg
figlink: /pmc/articles/PMC4571892/figure/F6/
number: F6
caption: Impact of HER2-mediated inhibition of MLK3 kinase activity on breast cancer
  cell death and tumorigenesis (survival). Inhibition of HER2-HER3 pathway by trastuzumab
  or lapatinib inactivates downstream PI3K/AKT. The inhibition of AKT leads to activation
  of MLK3 and its downstream MKK4/7-JNK axis and promotes HER2+ breast cancer cell
  death via induction of pro-apoptotic factors by AP1 transcription factor. On contrary,
  the activation of HER3 by its ligand, heregulin (HRG), or amplification of HER2
  activates the PI3K/AKT pathway and inhibition of MLK3 kinase activity via S674 phosphorylation
  by AKT. The inhibition of MLK3 ultimately prevents the downstream JNK-mediated AP1
  activation and induction of pro-apoptotic factors, finally leading to tumorigenesis.
papertitle: Human Epidermal Growth Factor Receptor 2 (HER2) Impedes MLK3 Kinase Activity
  to Support Breast Cancer Cell Survival.
reftext: Subhasis Das, et al. J Biol Chem. 2015 Aug 28;290(35):21705-21712.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9397199
figid_alias: PMC4571892__F6
figtype: Figure
redirect_from: /figures/PMC4571892__F6
ndex: 111e2ef6-df06-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4571892__zbc0401524110006.html
  '@type': Dataset
  description: Impact of HER2-mediated inhibition of MLK3 kinase activity on breast
    cancer cell death and tumorigenesis (survival). Inhibition of HER2-HER3 pathway
    by trastuzumab or lapatinib inactivates downstream PI3K/AKT. The inhibition of
    AKT leads to activation of MLK3 and its downstream MKK4/7-JNK axis and promotes
    HER2+ breast cancer cell death via induction of pro-apoptotic factors by AP1 transcription
    factor. On contrary, the activation of HER3 by its ligand, heregulin (HRG), or
    amplification of HER2 activates the PI3K/AKT pathway and inhibition of MLK3 kinase
    activity via S674 phosphorylation by AKT. The inhibition of MLK3 ultimately prevents
    the downstream JNK-mediated AP1 activation and induction of pro-apoptotic factors,
    finally leading to tumorigenesis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HRG
  - NRG1
  - SLC48A1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MAP3K11
  - MAP2K4
  - MAP2K7
  - MAPK8
  - MAPK9
  - MAPK10
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - FOSL1
  - FOSL2
  - hrg
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Mkk4
  - hep
  - bsk
  - AP-1gamma
  - Jra
  - kay
  - VPS34
  - MKK4
  - MKK7
  - AP1
  - Cancer
---
